Table 5.
Evaluation of the PM definition of the metabolic syndrome and individual criteria
| Sensitivity (male/female) | Specificity (male/female) | Likelihood ratio (95% CI) | Difference PM vs. AM (95% CI) | P value | |
|---|---|---|---|---|---|
| PM definition MetS | 0.63 (0.70/0.57) | 0.93 (0.94/0.91) | 9.27 (6.05; 14.19) | 2.3% (− 0.7%; 5.2%) | 0.175 |
| PM cholesterol | 0.29 (0.38/0.17) | 0.98 (0.98/0.98) | 15.80 (6.89; 36.27) | − 8.4% (− 11.4%; − 5.3%) | < 0.001 |
| PM hypertension | 0.80 (0.80/0.80) | 0.51 (0.48/0.58) | 1.64 (1.42; 1.89) | 34.5% (29.3%; 39.8%) | < 0.001 |
| PM triglycerides | 1 (NA/NA) | 0.30 (NA/NA) | 1.42 (1.34; 1.51) | 70.0% (65.7%; 74.2%) | < 0.001 |
| PM triglycerides w/o PM biochemistry | 0.50 (NA/NA) | 0.98 (NA/NA) | 31.50 (6.65; 151.21) | 1.4% (0.1%; 2.6%) | 0.077 |
| PM glucose | 0.87 (0.82/0.94) | 0.90 (0.92/0.88) | 8.81 (6.41; 12.10) | 7.9% (5.0; 10.8%) | < 0.001 |
All results are evaluated comparing the PM definition or criterion to the AM definition and the corresponding criterion. Gender-specific sensitivity and specificity for triglycerides was not calculated due to restrictions from Statistics Denmark regarding disclosure of aggregated microdata (N < 3)
AM ante mortem, CI confidence interval, MetS metabolic syndrome, PM post mortem, w/o without